Quick Takeaways
- This page summarizes Amy Stepnowski's Form 4 filing for HARTFORD INSURANCE GROUP, INC. (HIG).
- 12 reported transactions and 5 derivative rows are listed below.
- Filing timestamp: 06 May 2025, 16:18.
Amy Stepnowski - 05 May 2025 Form 4 Insider Report for HARTFORD INSURANCE GROUP, INC. (HIG)
- Role
- EVP
- Signature
- Anthony J. Salerno, Jr., Attorney-in-Fact
- Issuer symbol
- HIG
- Transactions as of
- 05 May 2025
- Net transactions value
- -$4,001,624
- Form type
- 4
- Filing time
- 06 May 2025, 16:18:59 UTC
- Previous filing
- 27 Feb 2025
- Next filing
- 19 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Amy Stepnowski filed Form 4 for HARTFORD INSURANCE GROUP, INC. (HIG) on 06 May 2025."
What Changed
- Previous filing in this sequence was filed on 27 Feb 2025.
- Current net transaction value: -$4,001,624.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Stepnowski Amy | EVP | ONE HARTFORD PLAZA, HARTFORD | Anthony J. Salerno, Jr., Attorney-in-Fact | 06 May 2025 | 0001820324 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HIG | Common Stock | Options Exercise | $1,481,511 | +28,562 | +97% | $51.87 | 58,061 | 05 May 2025 | Direct | |
| transaction | HIG | Common Stock | Options Exercise | $1,397,084 | +20,128 | +35% | $69.41 | 78,189 | 05 May 2025 | Direct | |
| transaction | HIG | Common Stock | Sale | $92,118 | -738 | -0.94% | $124.82 | 77,451 | 05 May 2025 | Direct | F1, F2 |
| transaction | HIG | Common Stock | Sale | $260,157 | -2,087 | -2.7% | $124.66 | 75,364 | 05 May 2025 | Direct | F1, F3 |
| transaction | HIG | Common Stock | Sale | $278,722 | -2,205 | -2.9% | $126.40 | 73,159 | 05 May 2025 | Direct | F1, F4 |
| transaction | HIG | Common Stock | Sale | $354,622 | -2,806 | -3.8% | $126.38 | 70,353 | 05 May 2025 | Direct | F1, F5 |
| transaction | HIG | Common Stock | Sale | $427,577 | -3,427 | -4.9% | $124.77 | 66,926 | 05 May 2025 | Direct | F1, F6 |
| transaction | HIG | Common Stock | Sale | $658,399 | -5,223 | -7.8% | $126.06 | 61,703 | 05 May 2025 | Direct | F1, F7 |
| transaction | HIG | Common Stock | Sale | $1,919,183 | -15,235 | -25% | $125.97 | 46,468 | 05 May 2025 | Direct | F1, F8 |
| transaction | HIG | Common Stock | Sale | $2,889,441 | -22,930 | -49% | $126.01 | 23,538 | 05 May 2025 | Direct | F1, F9 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HIG | Stock Option | Options Exercise | $0 | -28,562 | -100% | $0.000000 | 0 | 05 May 2025 | Common Stock | 28,562 | $51.87 | Direct | F10 |
| transaction | HIG | Stock Option | Options Exercise | $0 | -20,128 | -67% | $0.000000 | 10,065 | 05 May 2025 | Common Stock | 20,128 | $69.41 | Direct | F11 |
| holding | HIG | Stock Option | 26,079 | 05 May 2025 | Common Stock | 26,079 | $78.28 | Direct | F12 | |||||
| holding | HIG | Stock Option | 13,582 | 05 May 2025 | Common Stock | 13,582 | $95.74 | Direct | F13 | |||||
| holding | HIG | Stock Option | 13,836 | 05 May 2025 | Common Stock | 13,836 | $116.41 | Direct | F14 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Ms. Stepnowski on February 4, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |
| F2 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $124.48 - $125.33 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $124.27 - $125.02 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $126.37 - $126.51 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $126.32 - $126.51 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F6 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $124.35 - $125.34 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $125.56 - $126.49 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F8 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $125.32 - $126.32 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F9 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $125.37 - $126.36 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F10 | The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. |
| F11 | The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. |
| F12 | One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. |
| F13 | One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. |
| F14 | One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date. |